European Investment Bank
VC Fund
Luxembourg, Luxembourg
European Investment Bank is a VC fund in Luxembourg focused on Energy and Biotechnology. European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.
- Total investments:
- 600
- Last investment:
- Lead investor:
- 83%
Last updated:
For AI agents: llms.txt
Industries European Investment Bank invests in
Stages European Investment Bank invests in
Countries European Investment Bank invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 17 contacts → | |||
Round size
- Post-IPO Debt
- $16M–$587M
- Debt Financing
- $16M–$370M
- Venture - Series Unknown
- $8.7M–$110M
Investment Focus
Industry
- Energy 78 (13%)
- Biotechnology 78 (13%)
- Health Care 68 (11%)
- Renewable Energy 63 (11%)
- Manufacturing 60 (10%)
Stage
- Debt Financing 327 (55%)
- Post-IPO Debt 122 (20%)
- Venture - Series Unknown 24 (4%)
- Grant 11 (2%)
- Series B 9 (2%)
Country
- France 58 (10%)
- Germany 56 (9%)
- Italy 45 (8%)
- Spain 45 (8%)
- The Netherlands 31 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Gelsomina Vigliotti
Vice President
|
Vice President | Total investments: 11 | Find email | |
Myriam Rouis
Senior Investment Manager/Advisor - EIC Fund - Venture Capital
|
Senior Investment Manager/Advisor - EIC Fund - Venture Capital | Total investments: 1 | Find email | |
Ambroise Fayolle
Vice-President
|
Vice-President | Total investments: 45 | Find email | |
|
Andrus Ansip
Vice President
|
Vice President | Total investments: 0 | Find email | |
Edward Claessen
Head of Non-EU Infrastructure & Climate Funds
|
Head of Non-EU Infrastructure & Climate Funds | Total investments: 0 | Find email | |
| See all 17 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MedinCell is an injectable slow-release drug specialist company. | $15.4M / Post-IPO Debt / Oct 13, 2026 | ||
| RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding. | $58M / Series A / Oct 06, 2026 | ||
| Rezolv Energy develops, owns, and operates renewable power generation assets focused on large-scale wind and solar projects. The company is engaged in identifying project sites, securing land rights, managing permitting processes, and overseeing construction and grid connection activities. Its business model includes long-term power purchaseagreements with corporate and utility offtakers to supply electricity from renewable sources. Rezolv Energy also manages the ongoing operation and maintenance of its assets to ensure consistent power delivery. The company’s activities support the generation of electricity from renewable resources and the integration of these assets into existing energy systems. | $636.3M / Debt Financing / Sep 30, 2026 | ||
| VaxThera provides a production and research plants for biological products. They develop vaccines and medicines for the prevention and treatment of infectious diseases and other health problems. They develop vaccines for COVID-19, dengue, chikungunya, yellow fever, influenza, and zika. | $39.8M / Debt Financing / Sep 24, 2026 | ||
| Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue. | $21.7M / Debt Financing / Sep 23, 2026 | ||
| HighLife is a company focused on Transcatheter Mitral Valve Replacement (TMVR). The technology is intended for treatment of patients suffering from mitral valve regurgitation and is currently in a stage of clinical evaluation.The company was co-founded in 2010 by Mr. Georg Börtlein, President & CEO. The intent is to provide a minimallyinvasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. Ease and safety of use and delivery are key elements of the HighLife technology. | $90M / Venture - Series Unknown / Sep 22, 2026 | ||
| Morphotonics develops and sells nano and micro imprint structures as well as designs nanoimprint machine and supplies it. | $45.9M / Series B / Sep 22, 2026 | ||
| EcoGraf is building a vertically integrated business to produce high purity graphite for the lithium-ion battery market. | $2.3M / Grant / Sep 21, 2026 | ||
| We believe that all patients deserve the most innovative, open surgical treatment options so they can live their fullest lives. We’re on a mission to advance robotic technology that pushes the limits of soft tissue open surgery and opens new opportunities for surgeons to restore quality of life for more patients with complex conditions. TheSymani® Surgical System is a first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery to restore quality of life for more patients. | $19.6M / Venture - Series Unknown / Sep 16, 2026 | ||
| Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics. | $270M / Venture - Series Unknown / Sep 15, 2026 | ||
| See all 600 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does European Investment Bank invest in?
European Investment Bank invests primarily in Energy, Biotechnology and Health Care startups, most often at Debt Financing and Post-IPO Debt stage. Most of the 600 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does European Investment Bank invest in?
European Investment Bank typically joins rounds of $16M–$587M at Post-IPO Debt, $16M–$370M at Debt Financing and $8.7M–$110M at Venture - Series Unknown. These are whole funding-round sizes, not European Investment Bank's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds European Investment Bank took part in.
How do I contact European Investment Bank?
Public channels for European Investment Bank include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at European Investment Bank?
The team at European Investment Bank includes Gelsomina Vigliotti (Vice President), Myriam Rouis (Senior Investment Manager/Advisor - EIC Fund - Venture Capital) and Ambroise Fayolle (Vice-President), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
